Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
PaperCitations, authors & open-access status
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 329 citations, 2023 year and closed oa status.
329
Citations
2023
Year
closed
OA Status